A new study published in The BMJ says that GLP-1 drugs may help prevent and treat substance use disorders across all major addictive substances that were studied.

A study in The BMJ found GLP-1 drugs used for diabetes and obesity may also curb addiction by reducing cravings. Researchers ...

Residency-trained clinical pharmacists delivered tobacco use disorder treatment within HIV clinics over 10 visits across 24 weeks, supporting feasibility of embedding cessation services in routine HIV ...

Alberta officials are urging Prime Minister Mark Carney to reconsider 2024 regulations surrounding the sale of nicotine pouches, which limited consumers to only one brand and put them behind the ...

A large study of US veterans suggests that diabetes and weight-loss medicines may curb cravings and lower severe addiction outcomes, though clinical trials are still needed.

Colorado QuitLine gives free patches + up to $100 cash for finishing 5 coaching calls. Real people are quitting for good. Enroll today at 1-800-QUIT-NOW.

Experts warn that nicotine pouches are highly addictive and unsafe, prompting calls for stricter regulations and a nationwide ban.

I don’t drink anymore. I don’t smoke anymore.” He might have shrugged it off, but reports accumulated in his clinic and ...

They found that after three years of follow-up, the group taking GLP-1 agonists like Novo Nordisk's semaglutide and Eli Lilly's tirzepatide were 14% less likely to develop substance use disorders ...

The Uncas Health District is launching a free tobacco cessation program to help adults quit smoking and vaping.

Unlike tablets, which stay inside the body of the person taking them, topical drugs are absorbed through the skin - and they ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...